These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29359367)

  • 41. Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.
    Casula M; Colombino M; Satta MP; Cossu A; Lissia A; Budroni M; Simeone E; Calemma R; Loddo C; Caracò C; Mozzillo N; Daponte A; Comella G; Canzanella S; Guida M; Castello G; Ascierto PA; Palmieri G;
    Eur J Cancer; 2007 Jan; 43(1):137-43. PubMed ID: 17055252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families.
    Fidalgo F; Torrezan GT; Sá BCS; Barros BDF; Moredo LF; Valieris R; de Souza SJ; Duprat JP; Krepischi ACV; Carraro DM
    PLoS One; 2022; 17(1):e0262419. PubMed ID: 35085295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EDNRB gene variants and melanoma risk in two southern European populations.
    Spica T; Fargnoli MC; Hetet G; Bertrand G; Formicone F; Descamps V; Wolkenstein P; Dupin N; Lebbe C; Basset-Seguin N; Saiag P; Cambien F; Grandchamp B; Peris K; Soufir N
    Clin Exp Dermatol; 2011 Oct; 36(7):782-7. PubMed ID: 21507037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variation at KIT locus may predispose to melanoma.
    Bourillon A; Hu HH; Hetet G; Lacapere JJ; André J; Descamps V; Basset-Seguin N; Ogbah Z; Puig S; Saiag P; Bagot M; Bensussan A; Grandchamp B; Dumaz N; Soufir N
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):88-96. PubMed ID: 23020152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Body site of cutaneous malignant melanoma--a study on patients with hereditary and multiple sporadic tumours.
    Gillgren P; Brattström G; Frisell J; Palmgren J; Ringborg U; Hansson J
    Melanoma Res; 2003 Jun; 13(3):279-86. PubMed ID: 12777983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
    Burke LS; Hyland PL; Pfeiffer RM; Prescott J; Wheeler W; Mirabello L; Savage SA; Burdette L; Yeager M; Chanock S; De Vivo I; Tucker MA; Goldstein AM; Yang XR
    PLoS One; 2013; 8(8):e71121. PubMed ID: 23990928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hereditary malignant melanoma is not linked to the HLA complex on chromosome 6.
    Bale SJ; Greene MH; Murray C; Goldin LR; Johnson AH; Mann D
    Int J Cancer; 1985 Oct; 36(4):439-43. PubMed ID: 4044054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ICAM-1 polymorphisms and development of cutaneous malignant melanoma.
    Howell WM; Rose-Zerilli MJ; Theaker JM; Bateman AC
    Int J Immunogenet; 2005 Dec; 32(6):367-73. PubMed ID: 16313300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
    Monnerat C; Chompret A; Kannengiesser C; Avril MF; Janin N; Spatz A; Guinebretière JM; Marian C; Barrois M; Boitier F; Lenoir GM; Bressac-de Paillerets B
    Fam Cancer; 2007; 6(4):453-61. PubMed ID: 17624602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study.
    Blankenburg S; König IR; Moessner R; Laspe P; Thoms KM; Krueger U; Khan SG; Westphal G; Berking C; Volkenandt M; Reich K; Neumann C; Ziegler A; Kraemer KH; Emmert S
    Carcinogenesis; 2005 Jun; 26(6):1085-90. PubMed ID: 15731165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
    Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
    BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
    Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
    Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition.
    Ibarrola-Villava M; Kumar R; Nagore E; Benfodda M; Guedj M; Gazal S; Hu HH; Guan J; Rachkonda PS; Descamps V; Basset-Seguin N; Bensussan A; Bagot M; Saiag P; Schadendorf D; Martin-Gonzalez M; Mayor M; Grandchamp B; Ribas G; Soufir N
    Int J Cancer; 2015 May; 136(9):2109-19. PubMed ID: 25303718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects.
    Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W
    Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CDKN2A variants in a population-based sample of Queensland families with melanoma.
    Aitken J; Welch J; Duffy D; Milligan A; Green A; Martin N; Hayward N
    J Natl Cancer Inst; 1999 Mar; 91(5):446-52. PubMed ID: 10070944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.
    Teerlink CC; Huff C; Stevens J; Yu Y; Holmen SL; Silvis MR; Trombetti K; Zhao H; Grossman D; Farnham JM; Wen J; Facelli JC; Thomas A; Babst M; Florell SR; Meyer L; Zone JJ; Leachman S; Cannon-Albright LA
    J Natl Cancer Inst; 2018 Dec; 110(12):1380-1385. PubMed ID: 29659923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
    Itin PH; Fistarol SK
    Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland.
    Eldon BJ; Thorlacius S; Jonsson T; Jonasson JG; Kjartansson J; Bodvarsson S; Steingrimsson E; Rafnar T
    Eur J Cancer; 2006 May; 42(7):922-6. PubMed ID: 16530404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma.
    McCarron SL; Bateman AC; Theaker JM; Howell WM
    Int J Cancer; 2003 Nov; 107(4):673-5. PubMed ID: 14520709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.